株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

Medestea Research & Production S.p.A.の製品パイプライン分析

Medestea Research & Production S.p.A. - Product Pipeline Review - 2016

発行 Global Markets Direct 商品コード 317361
出版日 ページ情報 英文 34 Pages
即納可能
価格
本日の銀行送金レート: 1USD=115.18円で換算しております。

2016年12月31日まで 年末キャンペーン割引: Global Markets Direct社発行レポート
ご注意: ショッピングカートでは適用されませんので、割引価格についてはお問い合わせください

Back to Top
Medestea Research & Production S.p.A.の製品パイプライン分析 Medestea Research & Production S.p.A. - Product Pipeline Review - 2016
出版日: 2016年09月30日 ページ情報: 英文 34 Pages
概要

Medestea Research & Production S.p.A.はイタリアに本社をおく製薬企業で、炎症、胃腸疾患、心血管系疾患、免疫調節、代謝疾患、呼吸器疾患、希少疾患などの分野で、新薬や細胞由来治療薬などを提供しています。

当レポートでは、Medestea Research & Production S.p.A.における治療薬開発パイプラインの現況と各開発段階の比較分析、薬剤標的、作用機序、投与経路、分子タイプ別の治療薬の評価、最新の企業ニュースや発表、後期段階および中止されたプロジェクトに関する情報などを提供しています。

目次

Medestea Research & Production S.p.A.の基本情報

  • Medestea Research & Production S.p.A.の概要
  • 主要情報
  • 企業情報

Medestea Research & Production S.p.A.:R&Dの概要

  • 主な治療範囲

Medestea Research & Production S.p.A.:パイプラインのレビュー

  • 開発段階別のパイプライン製品
  • 単剤製品

Medestea Research & Production S.p.A.:パイプライン製品の概況

  • 臨床段階にあるパイプライン製品
    • 第2相の製品/併用療法モダリティ
    • 第1相の製品/併用療法モダリティ
  • 初期段階にあるパイプライン製品
    • 前臨床試験段階の製品/併用療法モダリティ
    • 創薬中の製品/併用療法モダリティ

Medestea Research & Production S.p.A.:薬剤プロファイル

  • Lysine Acetylsalicylate
  • AT-20
  • Adipose Tissue Derived Stem Cells
  • Deina
  • doxorubicin pegylated liposome
  • IAC VITA
  • MED-1101
  • Tribarcina
  • U-94
  • Monoclonal Antibodies to Inhibit HIV p17 for HIV / AIDS

Medestea Research & Production S.p.A.:パイプライン分析

  • 標的別
  • 投与経路別
  • 分子タイプ別
  • 作用機序別

Medestea Research & Production S.p.A.:本社と子会社の所在地

  • 本社
  • 支社および子会社

付録

図表一覧

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: GMDHC08144CDB

Summary

Global Markets Direct's, 'Medestea Research & Production S.p.A. - Product Pipeline Review - 2016', provides an overview of the Medestea Research & Production S.p.A.'s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Medestea Research & Production S.p.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of Medestea Research & Production S.p.A.
  • The report provides overview of Medestea Research & Production S.p.A. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Medestea Research & Production S.p.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Medestea Research & Production S.p.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate Medestea Research & Production S.p.A.'s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Medestea Research & Production S.p.A.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Medestea Research & Production S.p.A.'s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Medestea Research & Production S.p.A. Snapshot
    • Medestea Research & Production S.p.A. Overview
    • Key Facts
  • Medestea Research & Production S.p.A. - Research and Development Overview
    • Key Therapeutic Areas
  • Medestea Research & Production S.p.A. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Medestea Research & Production S.p.A. - Pipeline Products Glance
    • Medestea Research & Production S.p.A. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Medestea Research & Production S.p.A. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Medestea Research & Production S.p.A. - Drug Profiles
    • AT-20 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Deina - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • doxorubicin - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • IAC-VITA - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Lysine Acetylsalicylate - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • MED-1101 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Monoclonal Antibodies to Inhibit HIV p17 for HIV / AIDS - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Stem Cell Therapy for Acute Myocardial Infarction - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • Tribarcina - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • U-94 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • Medestea Research & Production S.p.A. - Pipeline Analysis
    • Medestea Research & Production S.p.A. - Pipeline Products by Target
    • Medestea Research & Production S.p.A. - Pipeline Products by Route of Administration
    • Medestea Research & Production S.p.A. - Pipeline Products by Molecule Type
    • Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action
  • Medestea Research & Production S.p.A. - Dormant Projects
  • Medestea Research & Production S.p.A. - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Medestea Research & Production S.p.A., Key Facts
  • Medestea Research & Production S.p.A. - Pipeline by Indication, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Stage of Development, 2016
  • Medestea Research & Production S.p.A. - Monotherapy Products in Pipeline, 2016
  • Medestea Research & Production S.p.A. - Phase II, 2016
  • Medestea Research & Production S.p.A. - Phase I, 2016
  • Medestea Research & Production S.p.A. - Preclinical, 2016
  • Medestea Research & Production S.p.A. - Discovery, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Target, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Route of Administration, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Molecule Type, 2016
  • Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action, 2016
  • Medestea Research & Production S.p.A. - Dormant Developmental Projects,2016
  • Medestea Research & Production S.p.A., Other Locations

List of Figures

  • Medestea Research & Production S.p.A. - Pipeline by Top 10 Indication, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Stage of Development, 2016
  • Medestea Research & Production S.p.A. - Monotherapy Products in Pipeline, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Target, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Route of Administration, 2016
  • Medestea Research & Production S.p.A. - Pipeline by Molecule Type, 2016
  • Medestea Research & Production S.p.A. - Pipeline Products by Mechanism of Action, 2016
Back to Top